本页面由Tiger Trade Technology Pte. Ltd.提供服务

Hemab Therapeutics Holdings, Inc.

29.80
-0.5900-1.94%
盘后:29.800.00000.00%16:10 EDT
成交量:44.20万
成交额:1,330.08万
市值:13.92亿
市盈率:-16.72
高:31.05
开:30.59
低:29.11
收:30.39
52周最高:55.42
52周最低:23.00
股本:4,670.54万
流通股本:1,675.00万
量比:0.97
换手率:2.64%
股息:- -
股息率:- -
每股收益(TTM):-1.7820
每股收益(LYR):-67.5613
净资产收益率:-46.99%
总资产收益率:-30.11%
市净率:3.06
市盈率(LYR):-0.44

数据加载中...

2026/09/24

重要事件披露

Form 8-K - Current report
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/11

重要事件披露

Form 8-K - Current report
2026/08/07

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/05

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/21

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/21

重要事件披露

Form 8-K - Current report
2026/05/11

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/11

重要事件披露

Form 8-K - Current report
2026/05/08

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/04

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/05/04

重要事件披露

Form 8-K - Current report
2026/04/30

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/28

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/27

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/04/10

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933